Structure-reactivity probes for active site shapes of cholesterol esterase by carbamate inhibitors

Abstract 4,4′-Biphenyl-di- N -butylcarbamate ( 1 ), ( S )-1,1′-bi-2-naphthyl-2,2′-di- N -butylcarbamate ( S - 2 ), ( S )-1,1′-bi-2-naphthyl-2- N -butylcarbamate-2′-butyrate ( S - 3 ), 2,2′-biphenyl-di- N -butylcarbamate ( 4 ), 2,2′-biphenyl-2- N -octadecylcarbamate-2′- N -octylcarbamate ( 5 ), 2,2′-biphenyl-2- N -octadecylcarbamate-2′- N -phenylcarbamate ( 6 ), 2,2′-biphenyl-2- N -butylcarbamate-2′-butyrate ( 7 ), 2,2′-biphenyl-2- N -butylcarbamate-2′-ol ( 8 ), 2,2′-biphenyl-2- N -octylcarbamate-2′-ol ( 9 ), ( R )-1,1′-bi-2- N -naphthyl-2-butylcarbamate-2′-ol ( R - 10 ), and glyceryl-1,2,3-tri- N -butylcarbamate ( 11 ) are prepared and evaluated for their inhibition effects on porcine pancreatic cholesterol esterase. All inhibitors are irreversible inhibitors of the enzyme. Carbamates 1 – 3 and 7 – 10 are the first alkyl chain and esteratic binding site-directed irreversible inhibitors due to the fact that the reactivity of the enzyme is protected by the irreversible inhibitor, trifluoroacetophenone in the presence of these carbamates. Carbamate 1 is the least potent inhibitor for the enzyme probably due to the fact that the inhibitor molecule adopts a linear conformation and one of the carbamyl groups of the inhibitor molecule covalently interacts with the first alkyl chain binding site of the enzyme while the other carbamyl group of the inhibitor molecule exposes outside the active site. With near orthogonal conformations at the pivot bond of biaryl groups, one carbamyl group of carbamates S - 2 , S - 3 , and R - 10 covalently binds to the first alkyl chain binding site of the enzyme while the other carbamyl, butyryl, or hydroxy group can not bind covalently to the second alkyl chain binding site probably due to the orthogonal conformations. Carbamates 4 – 9 and 11 are very potent inhibitors for the enzyme probably due to the fact that all these molecules freely rotate at the pivot bond of the biphenyl or glyceryl group and therefore can fit well into the bent-shaped first and second alkyl chains binding sites of the enzyme. Although, carbamates 4 – 6 and 11 are irreversible inhibitors of cholesterol esterase, the enzyme is not protected but further inhibited by trifluoroacetophenone in the presence of these carbamates. Therefore, carbamates 4 – 6 and 11 covalently bind to the first alkyl chain binding site of the enzyme by one of the carbamyl groups and may also bind to the second alkyl chain binding site of the enzyme by the second carbamyl group. Besides the bent-shaped conformation, the inhibition by carbamate 6 is probably assisted by a favorable π-π interaction between Phe 324 at the second alkyl chain binding site of the enzyme and the phenyl group of the inhibitor molecule. For cholesterol esterase, carbamates 8 – 10 are more potent than carbamates S - 2 , 4 , and 5 probably due to the fact that the inhibitor molecules interact with the second alkyl chain binding site of the enzyme through a hydrogen bond between the phenol hydroxy group of the inhibitor molecules and the His 435 residue in that site.